RPAM
Rhenman & Partners Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Buy |
149,217
+59,400
| +66% | +$7.47M | 2.37% | 10 |
|
|
2025
Q1 | $9.93M | Sell |
89,817
-10,500
| -10% | -$1.16M | 1.14% | 32 |
|
|
2024
Q4 | $13.7M | Buy |
100,317
+28,567
| +40% | +$3.9M | 1.41% | 29 |
|
|
2024
Q3 | $8.27M | Sell |
71,750
-3,805
| -5% | -$438K | 0.67% | 51 |
|
|
2024
Q2 | $10.4M | Buy |
75,555
+16,555
| +28% | +$2.28M | 1% | 36 |
|
|
2024
Q1 | $8.14M | Sell |
59,000
-3,000
| -5% | -$414K | 0.77% | 44 |
|
|
2023
Q4 | $8.17M | Buy |
62,000
+7,434
| +14% | +$980K | 0.82% | 45 |
|
|
2023
Q3 | $6.14M | Buy |
54,566
+14,566
| +36% | +$1.64M | 0.66% | 44 |
|
|
2023
Q2 | $3.77M | Sell |
40,000
-30,000
| -43% | -$2.83M | 0.4% | 62 |
|
|
2023
Q1 | $6.94M | Sell |
70,000
-15,000
| -18% | -$1.49M | 0.76% | 44 |
|
|
2022
Q4 | $10.2M | Buy |
85,000
+2,000
| +2% | +$239K | 1.06% | 36 |
|
|
2022
Q3 | $9.56M | Sell |
83,000
-12,000
| -13% | -$1.38M | 1% | 35 |
|
|
2022
Q2 | $9.26M | Sell |
95,000
-10,000
| -10% | -$975K | 1.05% | 36 |
|
|
2022
Q1 | $9.84M | Sell |
105,000
-46,100
| -31% | -$4.32M | 0.97% | 43 |
|
|
2021
Q4 | $12.8M | Buy |
151,100
+56,100
| +59% | +$4.75M | 0.85% | 44 |
|
|
2021
Q3 | $9.11M | Sell |
95,000
-10,000
| -10% | -$959K | 0.64% | 50 |
|
|
2021
Q2 | $10.2M | Sell |
105,000
-50,000
| -32% | -$4.87M | 0.69% | 56 |
|
|
2021
Q1 | $15.1M | Buy |
155,000
+5,000
| +3% | +$486K | 1.05% | 40 |
|
|
2020
Q4 | $14.4M | Buy |
150,000
+75,000
| +100% | +$7.19M | 1.17% | 38 |
|
|
2020
Q3 | $7.21M | Hold |
75,000
| – | – | 0.64% | 53 |
|
|
2020
Q2 | $9.15M | Sell |
75,000
-55,000
| -42% | -$6.71M | 0.99% | 42 |
|
|
2020
Q1 | $11.3M | Buy |
130,000
+10,000
| +8% | +$866K | 1.58% | 25 |
|
|
2019
Q4 | $12.9M | Sell |
120,000
-29,600
| -20% | -$3.18M | 1.41% | 29 |
|
|
2019
Q3 | $13.5M | Sell |
149,600
-30,400
| -17% | -$2.74M | 1.69% | 22 |
|
|
2019
Q2 | $15.2M | Buy |
180,000
+2,909
| +2% | +$246K | 1.67% | 26 |
|
|
2019
Q1 | $15.6M | Sell |
177,091
-24,000
| -12% | -$2.11M | 1.82% | 20 |
|
|
2018
Q4 | $14.4M | Buy |
201,091
+119,414
| +146% | +$8.53M | 1.64% | 25 |
|
|
2018
Q3 | $10M | Sell |
81,677
-28,700
| -26% | -$3.53M | 1.01% | 47 |
|
|
2018
Q2 | $10.8M | Buy |
110,377
+377
| +0.3% | +$37K | 1.11% | 44 |
|
|
2018
Q1 | $9.12M | Sell |
110,000
-7,969
| -7% | -$661K | 1.12% | 38 |
|
|
2017
Q4 | $9.15M | Buy |
117,969
+2,969
| +3% | +$230K | 1.24% | 31 |
|
|
2017
Q3 | $7.05M | Sell |
115,000
-5,000
| -4% | -$306K | 0.9% | 41 |
|
|
2017
Q2 | $5.52M | Buy |
120,000
+35,000
| +41% | +$1.61M | 0.79% | 50 |
|
|
2017
Q1 | $3.68M | Buy |
85,000
+45,000
| +113% | +$1.95M | 0.58% | 63 |
|
|
2016
Q4 | $1.55M | Hold |
40,000
| – | – | 0.3% | 79 |
|
|
2016
Q3 | $2.03M | Hold |
40,000
| – | – | 0.32% | 80 |
|
|
2016
Q2 | $1.82M | Sell |
40,000
-20,000
| -33% | -$909K | 0.32% | 79 |
|
|
2016
Q1 | $2.37M | Buy |
+60,000
| New | +$2.37M | 0.47% | 71 |
|